Saffron research in diabetes shows a selective inflammatory-marker result
A small evidence synthesis found a reduction in tumor necrosis factor alpha, while other measured inflammation and oxidative-stress markers showed no statistically significant changes.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Saffron supplementation was associated with lower tumor necrosis factor alpha levels than placebo in this review of people with diabetes. Other measured markers did not show statistically significant changes. The result concerns a laboratory marker and does not establish better diabetes control, fewer complications, or a broader health benefit from taking saffron.
The abstract does not provide the effect size for the marker that improved, or supplementation duration. It also reports a C-reactive protein estimate and confidence interval that appear internally inconsistent, limiting interpretation of that numerical result.
What researchers found
Tumor necrosis factor alpha level
Saffron supplementation compared with placebo; follow-up timing, effect size, and confidence interval for this endpoint were not reported.
The result was not uniform
The synthesis examined several laboratory measures related to inflammation and oxidative stress. Although tumor necrosis factor alpha decreased, the other reported markers did not show statistically significant changes, leaving the broader pattern uncertain.
What remains unanswered
A change in a laboratory marker does not demonstrate that patients feel better or develop fewer complications. The abstract focuses on marker levels and does not report evidence of those patient-centered outcomes.
The original publication
The efficacy of saffron supplementation on inflammation and oxidative stress in patients with type-2 diabetes mellitus: a meta-analysis.
Qin L, Hu N, Wang K et al.
Front Endocrinol (Lausanne) · 2025
- PubMed ID
- 40842498
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.